AAWSAP DIRD, Biosensors and BioMEMS: A Survey of the Present Field, March 2010

This Defense Intelligence Reference Document, dated 31 March 2010 and numbered DIA-08-1003-020, was prepared by the Defense Intelligence Agency's Defense Warning Office under its Advanced Aerospace Weapon System Applications Program. It surveys biosensors and biomedical microelectromechanical systems, covering brain-implanted micromachine neuroelectrodes, drug-delivery pumps, glucose sensors, neural interfaces, retinal prostheses, microfluidic lab chips, NASA cell-culture systems and microcantilever sensors. It concludes that the field is expanding rapidly, with nanomechanical systems expected to follow.

From the source: Release of 2026-09-18 Incident: 3/31/10, Las Vegas, Nevada. Released with redactions. This document is a Defense Intelligence Reference Document (DIRD), a technical reference format used by the Defense Intelligence Agency (DIA) to capture baseline knowledge on a specific topic for later analytic use. DIRDs are best understood as reference and synthesis products rather than as original research. It is one of 38 DIRDs produced under the Advanced Aerospace Weapon System Applications Program (AAWSAP) between 2009 and 2011. Because AAWSAP’s scope permitted a broad range of supporting topics, not every DIRD in the series directly concerns aerospace systems or future threat assessment. The following summary reflects the DIRD’s scope and framing at the time of writing and should not be read as implying current validation of the concepts discussed. This DIRD surveys biosensors and BioMEMS, a broad class of miniature biomedical devices that combine microscale engineering with sensing, fluid handling, stimulation, or drug-delivery functions. The report reviews major application areas including implantable blood-chemistry sensors, neural interfaces, neurostimulation, drug-delivery pumps, microfluidic systems, and emerging nanoscale extensions of the field, while emphasizing that miniaturization can improve sensitivity and enable functions that are difficult or impossible at larger scales. However, it also makes clear that practical development is constrained by biocompatibility, long-term stability, sensor drift, device degradation inside the body, and the high regulatory burden associated with implantable medical systems. The document presents BioMEMS as a rapidly growing and productive field whose future advances are likely to come through continued improvements in fabrication, materials, and reliability.

UNCLASSIFIED/ /P"OR: OP"P"l@IAL HS& 91'11.¥
Figure 30. Microfluidics in Glass........................................................................... 32
Figure 31. Commercial Lab-Chip Devices That Allow Analysis for Biomarkers of
Figure 32. Design of an Automated Cell Culture System for NASA Space
Applications Incorporating Microfluidics and Integrated Optical
Various Diseases Using On-Chip Electrophoresis in Microscale........... 34
Components ........................................................................................ 35
Figure 33. NASA Space Application of Microfluidic Cell Culture System Made by
Figure 34. Principle of a Microcantilever That Bends When It is Loaded With an
Figure 35. Scanning Electron Micrograph Showing a Cantilever Beam With a Single
Micromachining ................................................................................... 36
Adherent Mass .................................................................................... 37
Vaccinia Virus Particle ......................................................................... 38
Figure 36. Antibodies Attached to a Cantilever Array Create Different Specificities
to Substances in Blood That are Indicative of Cancer .......................... 38
UNCLASSIFIED/ (FOR OFFICIO! 1155 01!1.¥
V